Latest News

Header_FTRD_System

Market approval for colonic and diagnostic FTRD® in Brazil

Ovesco is proud to announce that the colonic and diagnostic FTRD® have received market approval
Header-OTSC-System_a_t_gc-Clip

2020 Latest ESGE Position Statement on diagnosis and management of iatrogenic endoscopic perforations recommends OTSC® for defects in size > 10 mm and

OTSC application is recommended for esophageal iatrogenic perforation > 10 mm, for gastric iatrogenic perforations
Header_FTRD_System

EFTR with the FTRD® should be considered as an alternative to surgery in gastrointestinal lesions that are not amenable to conventional endoscopic resection

A meta-analysis comprising 18 studies with overall 730 patients with difficult gastrointestinal lesions showed a
Header-OTSC-System_a_t_gc-Clip

OTSC® clipping for recurrent peptic ulcer bleeding is cost-effective as compared to a repeat of standard treatment

A cost analysis based on mathematic modelling determined the average cost of repeating standard treatment

Further news at a glance

Ovesco is proud to announce that the colonic and diagnostic FTRD® have received market approval
OTSC application is recommended for esophageal iatrogenic perforation > 10 mm, for gastric iatrogenic perforations
A meta-analysis comprising 18 studies with overall 730 patients with difficult gastrointestinal lesions showed a
A cost analysis based on mathematic modelling determined the average cost of repeating standard treatment
Ovesco Endoscopy awarded TOP 10 MEDICAL DIAGNOSTICS Solution Providers 2020 Ovesco Endoscopy has made it
Prof. Alexander Meining, Interventional and Experimental Endoscopy (InExEn), Internal Medicine II, University Hospital Würzburg, received
Expand your horizon on resection techniques in endoluminal surgery. This was the underlying topic of
stentfix OTSC was used in five complex cases who already had experienced stent migration and
92 patients with 117 non-acute full-thickness gastrointestinal defects (65 fistulas, 52 leaks) underwent OTSC therapy.
Resection techniques in endoluminal surgery July 15th, 2020, 4 – 5.30 pm CET Expand your
The novel submucosal injection agent LiftUp was successfully used in a first clinical case series
The patient had experienced esophageal perforation due to bougienage with a through-the-scope balloon, which led
Ovesco is proud to announce that the gastroduodenal FTRD® has been cleared for marketing by
Conference report of the Digestive Disease Week (DDW) 2020 FTRD® System: EFTR enables new therapeutic
106 patients with perforated peptic ulcer were treated with OTSC (n = 26) or conservative
16 patients with rectovaginal fistulas, 13 of those having undergone previous surgical interventions, were treated
In lesions > 2 cm, EMR+ outdoes its advantages: comparative trial demonstrates en-bloc resection rate
Ovesco is proud to announce that LiftUp® has received market approval in Australia and New
Because of its tissue apposition capabilities and easy en face application, OTSC is used as
In 7/10 patients with enterocutaneous fistula, OTSC application resulted in complete fistula closure. While NSQIP
Conference Report of the American College of Gastroenterology (ACG) 2019: OTSC®: Besides a RCT showing
„Everyone is just talking about it – ovesco does it“ – thanks to ARKTIK, climate-neutral
In 40 patients with rectal neuroendocrine tumors (NETs), EFTR resulted in 100 % macroscopically and
Ovesco has been able to achieve a large growth in turnover and employees in recent
Within the scope of the joint research project ‘nuEndo’, Ovesco Endoscopy AG is working with
In 96 patients with complex anorectal fistulas, OTSC Proctology application lead to an overall healing
Ovesco is proud to announce that LiftUp® has received market approval in Australia and New
„Everyone is just talking about it – ovesco does it“ – thanks to ARKTIK, climate-neutral
Conference Report of the United European Gastroenterology Week (UEGW) 2019: OTSC® shows superiority over conventional
A randomized controlled trial presented at the American College of Gastroenterology (ACG) meeting shows the
Conference of the German Society of Gastroenterology, and Digestive and Metabolic Diseases with Endoscopy Section
Ovesco Endoscopy AG partnered in an innovative training network focusing on “Wireless in-body environment communications”
In 156 patients with histologic evidence of adenocarcinoma, EFTR was technically successful in 92.3 %
The Gastrointestinal Endoscopy Editorial Board chooses resection techniques namely EMR/submucosal dissection and full-thickness resection as
EFTR in 30 patients with recurrent / residual colorectal neoplasia led to R0 resection in
The medical technology company located in Tuebingen will officially inaugurate its new building in the
The novel EMR+ technique uses an external additional working channel (AWC®) and a poloxamer agent
Ovesco Endoscopy AG donates € 3,314.05 to “Help for Sick Children”, the charity at the Tübingen
When compared to fistulectomy and primary sphincter reconstruction, the OTSC Proctology showed comparable results (93
To err is human – to help is, too! Due to a missed exhibition stand
In 50 patients with complex benign esophageal stenoses, endoscopic bougienage with the BougieCap was successful
For Ovesco Endoscopy AG, product innovation is among their core competences. Within the framework of
Digestive Disease Week – DDW 2019: – National and international multicenter studies confirm that the
On the occasion of the 1st Family Day in the new building, the ovesco Endoscopy
German Coloproctology-Congress of the German Society for Coloproctology (Deutsche Gesellschaft für Koloproktologie – DGK) together
93 % primary hemostasis was achieved with primary OTSC therapy (288 patients), 91 % with
In lesions of 3 cm, EMR+ reaches its best discriminatory power: R0 resection rate of
Technical success (lesion reached and resected) was achieved in 94.4 %. R0 resection was achieved
Conference of the German Society for Endoscopy and Imaging Procedures (DGE-BV) 2019 together with the
After moving to its new company headquarters in the Technology Park Tuebingen at the beginning
Pooled durable clinical success proportions of OTSC use were 87.5 % in hemorrhage, 81.4 %
ovesco Endoscopy AG moved to its new headquarters on April 29, 2019 and will thus
Prospective data from 51 FTRD-procedures shows technical success in 88 % (45/51) and a R0-resection
Ovesco is proud to announce that both the OTSC® System and the remOVE System including
6 consecutive T1-ERC patients underwent FTRD application which resulted in complete endoscopic resection in all
EFTR of duodenal lesions in 20 patients showed technical success in 17/20 (85.0 %), a
96.4 % hemostasis rate is reported from 286 emergency endoscopies for either upper or lower
Case series of 11 OTSC applications in 10 pediatric patients shows 100 % technical success
Italian single-center study of 20 consecutive patients with non-lifting lesions, adenoma recurrence/relapse of previous endoscopic
Ovesco Endoscopy AG merges all business entities in the Americas into its Ovesco Endoscopy USA
OTSC use in patients with refractory gastrointestinal diseases achieved an overall clinical success rate of
Stuttgart, December 11, 2018 – Three medical technology companies of Tübingen receive the familyNET Award
OTSC use decreased the rebleeding rate in high-risk (RS ≥ 8) patients with statistical significance
Conference Report of the United European Gastroenterology Week (UEGW) 2018: RESECT+: additional working channel (AWC®)
All 19 patients were treated successfully with the OTSC System. In 74 % of cases,
Multicenter study shows high technical success rate and significant improvement of dysphagia symptoms. B Walter
Conference of the German Society of Gastroenterology, and Digestive and Metabolic Diseases with Endoscopy Section
100 % primary hemostasis rate and improved management of rebleeding with OTSC® used as first
87.9 % R0-resection of non-lifting and submucosal colonic lesions with FTRD® Aepli P et al.,
66.6 % of patients with leaking from the “J” of the tip of an ileo-anal
Dr Wedi received the DGVS endoscopy research award for the FLETRock study, a multi-centric study
Bauder M et al., Department of Gastroenterology and Oncology, Ludwigsburg Hospital, Ludwigsburg, Germany, presented a
A systematic literature review evaluating efficacy and safety of the OTSC System in the management
Kobara H and colleagues, Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Kagawa,
Raithel M and colleagues, Department of Medicine II, University Erlangen, Germany presented data from three
As part of the “Tübinger Klimaschutzpakt” the Ovesco Endoscopy AG contributes to climate protection and
Ovesco is proud to announce that the OTSC® System including the OTSC® Anchor and the
Mizrahi I and colleagues, Digestive Disease Institute, Cleveland Clinic Florida, Weston, FL, USA, reported their
Honegger C and colleagues, Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland, presented
Gianfranco G. et al., Interventional Endoscopy Unit, Hospital Privé des Peupliers, Paris, France, presented a
OTSC has long been described in the scientific literature as a highly effective device for
Valli and colleagues, Division of Gastroenterology and Hepatology, Zurich University Hospital, Switzerland, reported about their
Ovesco welcomes following new distribution partners: Biogene Pharma Limited, a leading distributor of Medical Device
Conference of the German Society for Endoscopy and Imaging Procedures (DGE-BV) together with the learned
Prof Dr Alexander Meining, Department of Interventional and Experimental Endoscopy, University Hospital Ulm, received the
Within the scope of the Annual Meeting of the Chilean – Germany Chamber of Commerce
A. Braun and H. Dawson, Gastroenterology and Endoscopy, SRO Langenthal, Switzerland and Institute of Pathology,
The 48th Conference of the German Society for Endoscopy and Imaging Procedures (Deutsche Gesellschaft für
El Douaihy Y et al., Department of Internal Medicine, Staten Island University Hospital – Northwell
PD Dr Schmidt, Department of Inner Medicine II, Gastroenterology, Hepatology, Endocrinology and Infectiology, University Hospital
J Brandler and colleagues, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA, performed a
Ovesco is proud to announce the launch of the BougieCap. A new method for the
Ovesco announces that the remOVE System has been cleared by the US Food and Drug
Ovesco is proud to announce that the FTRD System including FTRD Marking Probe and FTRD
One of Germany’s first innovation awards, the state innovation award Baden-Württemberg – Dr.-Rudolf-Eberle-Prize – has
Ovesco is proud to announce that OTSC has received market approval in Peru. The product
Mangiafico S et al., Azienda Ospedaliero, University of Modena, Italy, presented at the 25th UEG
Chan SM and Lau JYW, Prince of Wales Hospital, The Chinese University of Hong Kong,
Ovesco is proud to announce that OTSC has received market approval in Taiwan. The product
Conference of the German Society of Gastroenterology, and Digestive and Metabolic Diseases with Endoscopy Section
Devan Kizhakee – new Commercial Director MEA, Australasia Devan Kizhakee Kurichyath has an extensive experience
In July Ovesco Endoscopy celebrated their groundbreaking ceremony for its new corporate headquarters for management,
Schmidt A, Beyna T, Schumacher B et al., affiliated to different German hospitals (Ludwigsburg, Freiburg,
Business news magazine brand eins rates Ovesco Endoscopy among the most innovative German companies. The
Innovative BougieCap and resection method developed in cooperation with Ovesco, randomized controlled study shows significant
Tübingen, July 19, 2017 – Groundbreaking ceremony marks beginning of construction Das Tübinger Medizintechnikunternehmen errichtet
Ovesco publishes an updated OTSC® update containing further relevant publications on research conducted with the
Ovesco is proud to announce that the FTRD System including FTRD Marking Probe and FTRD
Xiao X and Lau JY, Department of Surgery, Chinese University of Hong Kong, Hong Kong,
Ovesco is proud to announce that the FTRD System including FTRD Marking Probe and FTRD
Within the scope of the Annual Meeting of the British Society for Gastroenterology (BSG) from
R Manta et al., Niguarda-Ca Granda Hospital, Milan, Nuovo S. Agostino Hospital, Modena, Nuovo Regina
Within the scope of the DGE-BV / Endoscopy Live Congress in Berlin, the afternoon symposium
Dr. Malay Sharma from North India received the audiovisual award for the use of the
Dr. Schmidt, Department of Inner Medicine, Gastroenterology, Hemato-Oncology, Diabetology and Infectiology, Ludwigsburg Hospital, Germany, received
The internet platform Endoscopy Campus is providing the latest information about endoscopy. Together with DGVS
HJ Richter-Schrag and colleagues, Center of Interdisciplinary Gastrointestinal Endoscopy and Department of General and Visceral